AMBARELLA INC (AMBA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AMBA • KYG037AX1015

63.64 USD
+4.19 (+7.05%)
At close: Feb 6, 2026
63.64 USD
0 (0%)
After Hours: 2/6/2026, 8:17:40 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AMBA. AMBA was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While AMBA has a great health rating, there are worries on its profitability. AMBA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year AMBA was profitable.
  • In the past year AMBA had a positive cash flow from operations.
  • AMBA had negative earnings in each of the past 5 years.
  • AMBA had a positive operating cash flow in each of the past 5 years.
AMBA Yearly Net Income VS EBIT VS OCF VS FCFAMBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -10.60%, AMBA is not doing good in the industry: 76.99% of the companies in the same industry are doing better.
  • With a Return On Equity value of -13.50%, AMBA is not doing good in the industry: 71.68% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.6%
ROE -13.5%
ROIC N/A
ROA(3y)-17.32%
ROA(5y)-13.28%
ROE(3y)-20.64%
ROE(5y)-15.87%
ROIC(3y)N/A
ROIC(5y)N/A
AMBA Yearly ROA, ROE, ROICAMBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • The Gross Margin of AMBA (59.58%) is better than 84.07% of its industry peers.
  • In the last couple of years the Gross Margin of AMBA has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y0.84%
AMBA Yearly Profit, Operating, Gross MarginsAMBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

7

2. Health

2.1 Basic Checks

  • AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AMBA has more shares outstanding than it did 1 year ago.
  • AMBA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMBA Yearly Shares OutstandingAMBA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AMBA Yearly Total Debt VS Total AssetsAMBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • AMBA has an Altman-Z score of 10.00. This indicates that AMBA is financially healthy and has little risk of bankruptcy at the moment.
  • AMBA's Altman-Z score of 10.00 is fine compared to the rest of the industry. AMBA outperforms 71.68% of its industry peers.
  • There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10
ROIC/WACCN/A
WACC10.9%
AMBA Yearly LT Debt VS Equity VS FCFAMBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.66 indicates that AMBA has no problem at all paying its short term obligations.
  • AMBA has a Current ratio (2.66) which is in line with its industry peers.
  • AMBA has a Quick Ratio of 2.38. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
  • AMBA has a Quick ratio of 2.38. This is comparable to the rest of the industry: AMBA outperforms 57.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.38
AMBA Yearly Current Assets VS Current LiabilitesAMBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. Growth

3.1 Past

  • AMBA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.38%, which is quite impressive.
  • The Revenue has grown by 48.08% in the past year. This is a very strong growth!
  • Measured over the past years, AMBA shows a small growth in Revenue. The Revenue has been growing by 4.49% on average per year.
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
Revenue 1Y (TTM)48.08%
Revenue growth 3Y-4.97%
Revenue growth 5Y4.49%
Sales Q2Q%31.21%

3.2 Future

  • AMBA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.24% yearly.
  • The Revenue is expected to grow by 21.38% on average over the next years. This is a very strong growth
EPS Next Y457.4%
EPS Next 2Y138.64%
EPS Next 3Y91.18%
EPS Next 5Y79.24%
Revenue Next Year39.79%
Revenue Next 2Y23.93%
Revenue Next 3Y19.91%
Revenue Next 5Y21.38%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AMBA Yearly Revenue VS EstimatesAMBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AMBA Yearly EPS VS EstimatesAMBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 106.07, which means the current valuation is very expensive for AMBA.
  • Compared to the rest of the industry, the Price/Earnings ratio of AMBA is on the same level as its industry peers.
  • AMBA is valuated expensively when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 101.31, AMBA can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, AMBA is valued a bit more expensive than the industry average as 62.83% of the companies are valued more cheaply.
  • AMBA is valuated expensively when we compare the Price/Forward Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 106.07
Fwd PE 101.31
AMBA Price Earnings VS Forward Price EarningsAMBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, AMBA is valued a bit cheaper than the industry average as 76.99% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 42.27
EV/EBITDA N/A
AMBA Per share dataAMBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • AMBA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AMBA's earnings are expected to grow with 91.18% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y138.64%
EPS Next 3Y91.18%

0

5. Dividend

5.1 Amount

  • No dividends for AMBA!.
Industry RankSector Rank
Dividend Yield 0%

AMBARELLA INC

NASDAQ:AMBA (2/6/2026, 8:17:40 PM)

After market: 63.64 0 (0%)

63.64

+4.19 (+7.05%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-25
Earnings (Next)02-26
Inst Owners85.69%
Inst Owner Change-3.66%
Ins Owners2.64%
Ins Owner Change-2.41%
Market Cap2.72B
Revenue(TTM)373.85M
Net Income(TTM)-79.66M
Analysts78
Price Target95 (49.28%)
Short Float %5.75%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100.82%
Min EPS beat(2)28.03%
Max EPS beat(2)173.6%
EPS beat(4)4
Avg EPS beat(4)287.07%
Min EPS beat(4)28.03%
Max EPS beat(4)763.65%
EPS beat(8)8
Avg EPS beat(8)179.78%
EPS beat(12)12
Avg EPS beat(12)132.03%
EPS beat(16)16
Avg EPS beat(16)101.68%
Revenue beat(2)2
Avg Revenue beat(2)3.08%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)3.08%
Min Revenue beat(4)0.64%
Max Revenue beat(4)5.55%
Revenue beat(8)6
Avg Revenue beat(8)5.33%
Revenue beat(12)6
Avg Revenue beat(12)3.05%
Revenue beat(16)6
Avg Revenue beat(16)1.87%
PT rev (1m)0%
PT rev (3m)3.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)58.11%
EPS NY rev (1m)0%
EPS NY rev (3m)20.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.73%
Valuation
Industry RankSector Rank
PE 106.07
Fwd PE 101.31
P/S 7.27
P/FCF 42.27
P/OCF 33.94
P/B 4.6
P/tB 10.93
EV/EBITDA N/A
EPS(TTM)0.6
EY0.94%
EPS(NY)0.63
Fwd EY0.99%
FCF(TTM)1.51
FCFY2.37%
OCF(TTM)1.88
OCFY2.95%
SpS8.76
BVpS13.82
TBVpS5.82
PEG (NY)0.23
PEG (5Y)N/A
Graham Number13.66
Profitability
Industry RankSector Rank
ROA -10.6%
ROE -13.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.58%
FCFM 17.19%
ROA(3y)-17.32%
ROA(5y)-13.28%
ROE(3y)-20.64%
ROE(5y)-15.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y0.84%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 59.03%
Cap/Sales 4.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.38
Altman-Z 10
F-Score5
WACC10.9%
ROIC/WACCN/A
Cap/Depr(3y)54.66%
Cap/Depr(5y)54.82%
Cap/Sales(3y)4.47%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
EPS Next Y457.4%
EPS Next 2Y138.64%
EPS Next 3Y91.18%
EPS Next 5Y79.24%
Revenue 1Y (TTM)48.08%
Revenue growth 3Y-4.97%
Revenue growth 5Y4.49%
Sales Q2Q%31.21%
Revenue Next Year39.79%
Revenue Next 2Y23.93%
Revenue Next 3Y19.91%
Revenue Next 5Y21.38%
EBIT growth 1Y38.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-45.43%
EBIT Next 3Y-59.46%
EBIT Next 5Y60.54%
FCF growth 1Y301.5%
FCF growth 3Y-6.94%
FCF growth 5Y-9.01%
OCF growth 1Y184.31%
OCF growth 3Y-4.46%
OCF growth 5Y-3%

AMBARELLA INC / AMBA FAQ

Can you provide the ChartMill fundamental rating for AMBARELLA INC?

ChartMill assigns a fundamental rating of 5 / 10 to AMBA.


What is the valuation status of AMBARELLA INC (AMBA) stock?

ChartMill assigns a valuation rating of 3 / 10 to AMBARELLA INC (AMBA). This can be considered as Overvalued.


What is the profitability of AMBA stock?

AMBARELLA INC (AMBA) has a profitability rating of 2 / 10.


Can you provide the financial health for AMBA stock?

The financial health rating of AMBARELLA INC (AMBA) is 7 / 10.


What is the expected EPS growth for AMBARELLA INC (AMBA) stock?

The Earnings per Share (EPS) of AMBARELLA INC (AMBA) is expected to grow by 457.4% in the next year.